JBS: Buy Through Near-Term Volatility — Thesis at Risk in 2H26, But Upside Still Compelling

Hook & thesis

JBS N.V. is one of the world's largest meat processors and it currently trades at $12.20 with a market cap of roughly $13.0 billion. The stock is cheap on headline multiples - a P/E of 7.3 and a P/B of 1.51 - while the industry environment still favors suppliers: U.S. cattle inventories are at multi-decade lows, pushing wholesale beef prices sharply higher. That supply backdrop, combined with proactive liability management via recent note exchange and tender actions, underpins our continued BUY.

That said, we are explicit: our thesis has a conditional element. If JBS's gross and operating margins reverse materially in 2H26 because of demand slippage, a rapid drop in beef prices, or renewed funding stress, we would consider the thesis broken. Until then, the combination of cheap valuation, structural supply tightness, and balance-sheet moves makes JBS an actionable long.

Why the market should care - business and fundamental driver

JBS is a global protein company that sells beef, pork, lamb and poultry into retail and foodservice channels. The primary near-term fundamental driver is beef supply. Ground beef hit a record $6.67 per pound (+20.5% year-over-year) as U.S. cattle herd size fell to 85 million head - the smallest since 1951 - constraining beef availability and keeping wholesale prices elevated. USDA forecasts production to decline further in 2026 and expects cattle prices to average $240 per cwt, roughly 7% above 2025. Biological lags mean new cattle supplies won't materially relieve the market before 2028.

For a processor like JBS, higher cattle prices have a two-way effect: input costs rise, but processors with scale and diversified geography can protect or even expand margins during periods of strong retail demand and pricing pass-through. Recent company actions also matter. JBS completed registered exchange offers for roughly $5.25 billion of senior notes (settling 01/14/2026) and ran targeted tender activity in April 2026 that reduced near-term maturities and increased optionality on the debt profile. That behavior reduces refinancing risk and is a positive governance sign given the industry’s capital intensity.

Evidence & numbers that support the call

• Valuation: Market cap near $13.04 billion but a P/E of ~7.3 and P/B 1.51 indicate the market is pricing modest earnings recovery or ongoing margin risk rather than growth. For an asset-heavy, cash-generative processor, those multiples are compelling if margins stabilize.
• Price context: Shares trade at $12.20, roughly 34% below the 52-week high of $18.65 and only slightly above the 52-week low of $11.49. The proximity to the low reflects short-term risk aversion but not necessarily a change in the structural supply story.
• Liquidity & capital markets: The company successfully executed exchange offers for about $5.25 billion of notes (participation near 99% in January 2026) and ran a cash tender program in April that was oversubscribed for certain tranches; the 2034 notes saw $1.32 billion tendered against a $1.2 billion acceptance cap. Those moves demonstrate active liability management to extend maturities and lower refinancing concentration.
• Operational backdrop: Ground beef at $6.67/lb (+20.5% YoY) and USDA forecasts of lower beef production in 2026 support continued pricing power through at least the next several quarters. JBS’s expansion into adjacent protein categories (example: Mantiqueira USA acquiring Hickman's Egg Ranch) diversifies revenue streams and reduces dependence on any single commodity cycle.
• Technicals: Price sits near short-term moving averages (10-day SMA ~ $12.17; 20-day SMA ~ $12.22) with a 50-day SMA at $14.29. RSI near 40 indicates the stock is not overbought; MACD shows modest bullish momentum. Short interest has been elevated and rising in recent settlements (27.8M shares at the 05/29/2026 settlement) which can amplify moves on positive catalysts.

Valuation framing

At a market cap of ~ $13.0 billion and a P/E ~7.3, JBS is priced as a low-growth, cyclical commodity business rather than a premium branded food company. That is reasonable in a sector where margins swing with livestock cycles. The current multiple implies the market is assigning little upside for margin recovery or successful capital management beyond what’s already announced. If cattle supply remains constrained and JBS preserves operating leverage, earnings could re-rate toward mid-teens multiples relative to cyclic troughs.

Absent a peer dataset in this write-up, think of the valuation qualitatively: processors with scale and global diversification typically trade at modest premiums to regional rivals when margins are improving because scale translates to procurement and distribution advantages. JBS's ongoing debt-exchange and tender actions reduce near-term refinancing uncertainty, improving the chance of a valuation re-rate if margins hold.

Catalysts (2-5)

• Continued strength in beef prices and tight cattle supplies - should sustain gross margins for processors.
• Quarterly results showing sequential margin expansion or better-than-expected price pass-through to retail.
• Further debt simplification or buybacks / dividend actions funded by free cash flow, which would reduce perceived leverage risk.
• Positive operational news from expanded protein lines (e.g., Mantiqueira entry into U.S. eggs) that adds scale to U.S. operations.

Trade plan (actionable)

This is a long idea sized for investors comfortable with commodity cyclicality. The plan assumes the trade is intended to last for the long-term cycle while monitoring 2H26 for the 'break' conditions described below.

• Entry price: $12.20
• Stop loss: $11.40 - set below the recent 52-week low of $11.49 to allow for intraday noise while limiting downside on a clear technical failure.
• Target price: $16.00 - a realistic upside reflecting partial mean reversion toward the stock's prior trading range and a re-rating if operational trends hold.
• Horizon: long term (180 trading days) - we expect structural supply tightness and the impact of balance-sheet actions to play out over multiple quarters. Review position at 90 days for any signs of the thesis breaking.

Rationale: Entry at $12.20 buys valuation support with upside if margins stabilize or expand. The $11.40 stop preserves capital if the stock breaks below its cycle low. The $16.00 target captures significant upside without assuming a full recovery to the $18.65 52-week high; it also allows for profit-taking should sentiment and multiples begin to re-rate the name.

Risks and counterarguments

Below are the main risks that could invalidate the trade and at least one counterargument to the bullish case.

• Margin shock from demand weakness: If consumer demand weakens materially and retailers push back on price pass-through, processors could see gross margin compression. This is the single largest operational risk to the thesis and is exactly what would push us to re-evaluate in 2H26.
• Commodity-cycle reversal: The current tight cattle supply is biological and can unwind over time; if cattle supply expands faster than expected or prices retreat, JBS’s revenue and margin tailwind could evaporate quickly.
• Liquidity or refinancing stress: While recent exchanges and tenders reduce near-term maturity concentration, JBS remains a capital-intensive business. Any sudden deterioration in access to credit markets or a sovereign/currency shock in key markets could reintroduce funding pressure.
• Execution risk with diversification: Expansion into adjacent proteins (e.g., eggs) requires integration and execution. Missteps or unexpected capex could dent free cash flow and investor sentiment.
• Counterargument: The market could be correctly pricing persistent structural risks tied to regulation, higher long-term feed costs, or secular shifts away from red meat in some markets. If these forces accelerate, a low P/E could be warranted and JBS might not re-rate despite temporary beef price strength.

What would change my mind

I will downgrade from BUY if, by the start of 2H26, one or more of the following occur:

• Quarterly gross margins show a sustained downtrend with negative operating leverage despite the high beef prices, suggesting demand loss or inability to pass costs through.
• Evidence of renewed liquidity stress: failed tenders, widening credit spreads for JBS paper, or inability to access committed facilities at reasonable cost.
• Unexpected regulatory action or a material food-safety incident that meaningfully reduces processing throughput or forces costly remedial actions.

Conclusion

JBS remains a BUY for investors willing to accept commodity cyclicality in exchange for cheap earnings and meaningful upside if the current tight supply environment persists. The company has taken steps to simplify its liability profile and is positioned to benefit from elevated beef prices in the near term. Our trade is explicit: enter at $12.20, stop at $11.40, target $16.00, and plan for a long-term horizon of 180 trading days while monitoring 2H26 for a clearly defined break in the thesis. If margins deteriorate or funding stress returns, we will be quick to reassess.

Note: Maintain position size appropriate to your portfolio and be prepared for higher-than-normal volatility driven by commodity price moves and short-interest dynamics.